Oncopharmpod
Neoadjuvant ddMVAC (bladder) & Nivo + Chemo (NSCLC)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:17:10
- More information
Informações:
Synopsis
Results from VESPER are now published, so we revisit neoadjuvant ddMVAC and its place as SOC in bladder cancer. Nivolumab nets a new approval with chemo for neoadjuvant treatment of NSCLC. A new CAR-T product is approved for multiple myeloma.
